RT Book, Section
A1 Alysandratos, Konstantinos-Dionysios
A1 Herriges, Michael J.
A1 Kotton, Darrell N.
A2 Grippi, Michael A.
A2 Antin-Ozerkis, Danielle E.
A2 Dela Cruz, Charles S.
A2 Kotloff, Robert M.
A2 Kotton, Camille Nelson
A2 Pack, Allan I.
SR Print(0)
ID 1194945733
T1 Stem Cells and Respiratory Disease: Prospects for the Future
T2 Fishman’s Pulmonary Diseases and Disorders, 6e
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781260473988
LK accessmedicine.mhmedical.com/content.aspx?aid=1194945733
RD 2025/03/21
AB Advances  in  stem  cell  research  offer  unprecedented  opportunities  to  develop  new  treatments,  disease  models,  and  drug  screens  for  previously  untreatable  conditions*.  These  discoveries  have  captivated  the  imagination  of  the  lay  press  and  have  inspired  hope  in  patients,  clinicians,  and  scientists.  Inevitably,  in  an  emerging  new  field,  there  are  false  starts  that  accompany  promising  discoveries.  If  rigorous  researchers  in  the  field  have  difficulty  discerning  hype  from  hope,  what  is  a  busy  clinician  to  do  when  confronted  with  basic  questions,  such  as:  “Is  stem  cell  therapy  available  for  my  lung  disease?”  or  “Shall  I  bank  my  baby’s  cord  blood  in  case  he/she  develops  cystic  fibrosis  or  emphysema?”  This  chapter  is  designed  to  describe  the  quickening  pace  of  stem  cell  and  regenerative  medicine  research  related  to  lung  disease  and  to  place  the  latest  discoveries  in  a  historic  context,  before  discussing  future  prospects.